These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 3549061
21. Protein dependence of digoxin determination on the Abbott-TDX. Yatscoff RW, Dalton JG, Desjardins PR. Clin Biochem; 1984 Dec; 17(6):348-50. PubMed ID: 6518649 [Abstract] [Full Text] [Related]
22. Evaluation of the fluorescence polarization immunoassay for quantitation of digoxin in serum. Al-Fares AM, Mira SA, el-Sayed YM. Ther Drug Monit; 1984 Dec; 6(4):454-7. PubMed ID: 6515706 [Abstract] [Full Text] [Related]
23. Syva Emit 2000 and Roche "on line" subject to less interference by digoxin-like factors than Abbott TDx FPIA in newborns and pregnant women. Sánchez BM, De Cos MA, Peralta FG, Arribas C, Armijo JA. Clin Chem; 1996 Jun; 42(6 Pt 1):974-6. PubMed ID: 8665693 [No Abstract] [Full Text] [Related]
24. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods]. Jankowski A, Karwowski J, Marzec A, Kretowicz W, Nartowicz E. Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482 [Abstract] [Full Text] [Related]
25. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients. Avendaño C, Alvarez JS, Sacristan JA, Adin J, Alsar MJ. Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650 [Abstract] [Full Text] [Related]
26. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency]. Li JH, Wu ZG, Xu JQ, Zhou Y. Yao Xue Xue Bao; 1997 Nov; 32(3):174-7. PubMed ID: 11327016 [Abstract] [Full Text] [Related]
27. Positive interference of merthiolate in the TDx digoxin assay in control samples used in the Belgian External Quality Assessment (EQA) Scheme. Devleeschouwer N, Libeer JC, Schiettecatte J, Maes V, Demolder J, Debusschere PM, Gorus F. Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):935-7. PubMed ID: 7696443 [Abstract] [Full Text] [Related]
28. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors. Graves SW, Sharma K, Chandler AB. Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385 [Abstract] [Full Text] [Related]
29. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants. Ng PK, LeGatt D, Coates J, Collins-Nakai RL. Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741 [Abstract] [Full Text] [Related]
37. Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Pudek MR, Seccombe DW, Jacobson BE, Whitfield MF. Clin Chem; 1983 Nov; 29(11):1972-4. PubMed ID: 6627637 [Abstract] [Full Text] [Related]